Friday, May 25, 2007

Use of diabetes, cancer drugs on rise

America’s health care system, already burdened by skyrocketing costs, faces more challenges as reports indicate spending will increase over the next couple of years on drugs to combat diabetes and cancer.

An epidemic of diabetes, combined with more aggressive treatments, could result in a near 70% increase in spending on endocrine and diabetes therapies from 2007 to 2009, according to a report released yesterday by the pharmacy benefit manager Medco. An aging population and rising obesity rates are expected to push spending on diabetes medications upward by 16% to 20% annually, as use increases each year by 8% to 10%.

Article provided by Benefit News 5-17-07.

0 Comments:

Post a Comment

<< Home